EN IT

Media

Press Releases 2008

28.11.2008	AIGO starts a multicenter prospective study to assess the diagnostic value of SCCA-IgM for liver cancer
15.10.2008	University of Brescia validates PSA-IgM 3-fold improvement for prostate cancer diagnosis
25.09.2008	EDRN enrols Xeptagen biomarker (SCCA-IgM) in a retrospective case-control matched-design study
01.08.2008	Xeptagen's SCCA-IgM proposed in the follow-up of cirrhotic patients presenting SCCA-PD polymorphism
21.07.2008	EJCI publishes Xeptagen results on tumor specific induction of immune complexes
14.07.2008	Xeptagen HCC biomarker included in a NCI multicenter study
18.04.2008	Puglia health authority endorses a screening program for patients at risk of developing hepatocellul
31.01.2008	SCCA-IgM effective in identifying at risk patients for cirrhosis development